UBS Group’s Organon & Co OGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $57.7M | Buy |
5,959,792
+4,185,464
| +236% | +$40.5M | 0.01% | 1099 |
|
|
2025
Q1 | $26.4M | Sell |
1,774,328
-1,518,225
| -46% | -$22.6M | ﹤0.01% | 1608 |
|
|
2024
Q4 | $49.1M | Buy |
3,292,553
+2,876,254
| +691% | +$42.9M | 0.01% | 1134 |
|
|
2024
Q3 | $7.96M | Sell |
416,299
-1,737
| -0.4% | -$33.2K | ﹤0.01% | 1866 |
|
|
2024
Q2 | $8.65M | Sell |
418,036
-212,415
| -34% | -$4.4M | ﹤0.01% | 1704 |
|
|
2024
Q1 | $11.9M | Buy |
630,451
+87,120
| +16% | +$1.64M | ﹤0.01% | 1510 |
|
|
2023
Q4 | $7.83M | Sell |
543,331
-114,581
| -17% | -$1.65M | ﹤0.01% | 1627 |
|
|
2023
Q3 | $11.4M | Buy |
657,912
+308,470
| +88% | +$5.36M | ﹤0.01% | 1333 |
|
|
2023
Q2 | $7.27M | Sell |
349,442
-10,372
| -3% | -$216K | ﹤0.01% | 1621 |
|
|
2023
Q1 | $8.46M | Sell |
359,814
-334,003
| -48% | -$7.86M | ﹤0.01% | 1461 |
|
|
2022
Q4 | $19.4M | Buy |
693,817
+101,023
| +17% | +$2.82M | 0.01% | 1019 |
|
|
2022
Q3 | $13.9M | Buy |
592,794
+147,065
| +33% | +$3.44M | 0.01% | 1100 |
|
|
2022
Q2 | $15M | Buy |
445,729
+16,505
| +4% | +$557K | 0.01% | 1119 |
|
|
2022
Q1 | $15M | Sell |
429,224
-79,572
| -16% | -$2.78M | 0.01% | 1225 |
|
|
2021
Q4 | $15.5M | Buy |
508,796
+14,687
| +3% | +$447K | ﹤0.01% | 1257 |
|
|
2021
Q3 | $16.2M | Sell |
494,109
-308,873
| -38% | -$10.1M | 0.01% | 1237 |
|
|
2021
Q2 | $24.3M | Buy |
+802,982
| New | +$24.3M | 0.01% | 1002 |
|